Preventing schizophrenia in teens with family history
Part of Mental health clinical trials.
This study tests whether a program can help prevent schizophrenia and related conditions in young people who have a family history of these illnesses. It focuses on identifying early risk factors and providing support to reduce the chance of developing the disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a close family member (like a parent, sibling, grandparent, or uncle) with schizophrenia or a related severe mental illness.
- You have at least two risk factors for schizophrenia that the study is trying to address.
- You are currently stable and haven't changed any psychiatric medications in the past 4 weeks.
- You are willing to participate in the study and, if under 18, your parent or guardian also agrees.
- You have never been diagnosed with a psychotic disorder or been at clinical high risk for psychosis.
- You do not have major medical or neurological conditions, or significant intellectual disabilities that would prevent you from completing the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This research study looks at how the brain changes in young people who are at high risk for developing psychosis. It aims to find better ways to predict and prevent psychosis by using brain imaging and thinking tests.
This study tests a program to help young people who are at risk for psychosis and have had suicidal thoughts or behaviors. The program also involves a caregiver, like a family member, to provide support.
This trial tests a staged (“step-based”) mental health program for people ages 12–25 who have early warning signs that could develop into psychosis. It may help by targeting symptoms early and reducing the chance of worsening over time.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This trial tests a culturally adapted talking therapy to help young people who are at risk of having their first episode of psychosis. If you are between 16 and 35, have some early warning signs but no history of psychosis, this study might be a good fit.
Hear when a new Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.